Diagnóstico y tratamiento de enfermedad poliquística hepática aislada

Abstract

Polycystic liver disease is a genetic-based and asymptomatic pathology characterized by genetic mutations in genes that encode proteins responsible for the transport of fluid and growth of epithelial cells in the liver, which causes the liver tissue to be replaced by multiple cysts. Objectives: To verify the epidemiology of polycystic liver disease, determine which are the most recommended diagnostic methods, analyze how diagnosed it is. Materials and Methods: the low frequency of the diagnosis of this disease has led us to carry out a systematic review with a descriptive, qualitative and cross-sectional approach, in order to identify which is the most used diagnostic method, and the most relevant treatments in polycystic liver disease , so a search was carried out in highly specialized databases, PUBMED, GOOGLE SCHOOLAR, SCIENCEDIRECT. Using keywords to search for them such as: “cyst”, “hepatic”, “polycystic”, and biasing them according to the quartile of the indexed journal to which they belong, prioritizing quartiles 1, 2 and 3, their year of publication, and relevance on the topic using Scimago Journal & Country Rank. Conclusion: Polycystic liver disease is a poorly diagnosed pathology in isolation due to its primary asymptomatic nature, and is less common in isolation. Imaging tests proved to be the main option, specifically ultrasonography to a greater extent. Octreotide has been further studied as a medical treatment and surgical options vary according to the clinical presentation.